The RUNX2 gene helps guide the formation of bones and teeth, especially during early growth. If it does not work properly, bone development can be altered, and pathogenic variants in the RUNX2 gene are a known cause of cleidocranial dysplasia, a condition that may involve delayed closing of the skull, differences in the collarbones, delayed tooth eruption, and short stature. This gene plays an important role in turning early cells into bone forming cells. RUNX2 is mainly known in medicine rather than popular culture.
What is a gene?
Genes are stretches of DNA that carry instructions your cells use to make molecules or regulate activities in the body. Some genes provide the directions for producing proteins, which are the active parts of cells. Others mainly help determine when, where, and how much certain processes take place. Taken together, genes affect how the body develops and works, and they can influence how you respond to food, stress, and medications. To explore this subject in more detail, you can learn more in the LearnHub.
Overview
RUNX2Gene function
What if the gene works
The RUNX2 gene helps guide cells that build bone. It is especially important for normal skull, collarbone, and tooth development.
Risk
What if the gene does not work
Variants in the RUNX2 gene most often cause cleidocranial dysplasia, which affects skull and collarbone development and tooth eruption. Effects can range from milder to more severe, influencing height, dental crowding, and how noticeable bone changes are.
Treatment
What does that mean for your treatment
For a pathogenic or loss-of-function variant in the RUNX2 gene, no RUNX2-specific drug treatment or management approach is currently established. Care is guided by the person’s bone, dental, hearing, and orthopedic needs rather than by a gene-directed medicine, and the RUNX2 gene is also being studied as a biomarker and possible drug target in bone biology and some cancers.
Conditions associated with RUNX2
Gene function
What if the gene works
Your body uses the RUNX2 gene to guide how bone building cells develop and do their job. It acts like a control switch, turning on other genes needed for bone growth, tooth development, and the hardening of the skeleton. Understanding how the RUNX2 gene supports bone growth and tooth development helps explain how your skeleton forms and renews itself over time.
Inside bone building cells, the RUNX2 gene acts like a control switch for other genes. It helps turn on the instructions needed for growth and for making bone tissue.
The RUNX2 gene helps immature cells become osteoblasts, the cells that build bone. This gives the body a steady supply of cells that can lay down the basic bone framework.
This gene supports bone growth by helping bones form in the right places and at the right time. It is especially important for parts of the skull, jaw, and collarbones.
After the basic framework is made, the RUNX2 gene helps osteoblasts mature and support mineralization (the process that makes bone hard). This helps bones gain their usual strength and structure.
What is a variant?
A genetic variant is a minor change in the DNA sequence of a gene. These changes are common and help shape normal human diversity, including differences in appearance, metabolism, or how the body responds to environmental influences. Many variants have no noticeable effect and are simply part of natural genetic variation. In some cases, though, a variant can change how a gene functions more substantially and may contribute to or cause a genetic condition.
Genetic variants
What if the gene does not work
Variants in the RUNX2 gene can change the shape, stability, or DNA binding of its protein, so it cannot properly switch on other genes needed for bone and tooth development. This is how variants influence the RUNX2 gene's function at the cell level. Milder variants may leave some activity, while more disruptive variants, including protein-shortening changes, can sharply reduce activity and are linked to cleidocranial dysplasia, sometimes with earlier or more marked features.
How variants are linked to conditions
Pathogenic variants in the RUNX2 gene cause cleidocranial dysplasia, a genetic condition that affects bone growth and tooth development. The link between RUNX2 gene variants and cleidocranial dysplasia is well established, and common features include delayed closure of the skull bones, underdeveloped or absent collarbones, dental crowding, and extra or late-erupting teeth. Most people with a pathogenic RUNX2 variant have signs of this condition, though the pattern can vary from person to person.
A variant is not necessarily a diagnosis
Genetic variants are a routine part of human biology and are widely found in the general population. Most do not have a direct effect on health and simply reflect natural human variation. For many genes, carrying a variant associated with a condition indicates a possible link rather than a definite diagnosis, especially when several genes and environmental factors play a role. In some situations, though, a single well-characterized variant in a specific gene can be enough to confirm a diagnosis.
Are there things that can increase or change my risk?
For RUNX2, risk is mainly changed by whether a disease-causing variant is present and whether it runs in your family. If a parent carries a RUNX2 variant, each child has a 1 in 2, or 50%, chance of inheriting it. There is not enough evidence to say that lifestyle changes lower the chance of having the condition.
Inheritance of RUNX2 variants
RUNX2-related cleidocranial dysplasia usually follows an autosomal dominant inheritance pattern. If a parent carries a pathogenic variant in the RUNX2 gene, each child has a 50% chance of inheriting it. Some people have a new (de novo) RUNX2 variant, which means it arose for the first time in them rather than being passed down from either parent. In families affected by RUNX2 gene inheritance, either parent can pass the variant to a son or daughter.
What does my RUNX2 result mean for my family?
A disease-causing change in the RUNX2 gene is usually passed in a dominant pattern, so close relatives such as parents, brothers, sisters, and children may also carry the same change and may have similar features, even if those features are mild. Each child of an affected parent has a 1 in 2 chance of inheriting it. Some RUNX2 changes happen for the first time in one person, so a parent is not always the source.
Genetic information
Genetic testing
How you find out about variants
Variants in the RUNX2 gene are usually found with genetic testing for cleidocranial dysplasia, using a blood sample or saliva sample. A lab reads the gene's DNA sequence and may also check for missing or extra pieces. Results can confirm a RUNX2-related diagnosis in someone with suggestive features or help clarify a family finding.
When should I consider getting a genetic test?
You may want to consider RUNX2 testing if you or your child has signs of cleidocranial dysplasia, such as unusually flexible shoulders, delayed loss or eruption of teeth, or a family history of the condition. Testing can help confirm the diagnosis and clarify whether it runs in the family.
A genetic result is only one part of your health story
Genetic findings can offer useful insight, but how much they reveal varies by the condition and the type of variant involved. Over time, lifestyle, environment, age, and medical history all play a part in how the body functions. In some conditions, especially those influenced by many genes, genetic information adds context rather than certainty and is best understood alongside other parts of care. In other situations, a genetic result may give a clear answer. In areas such as medication response, genetic results can also help put personal experiences into context.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how your body responds to medicines. Some people break down a drug more quickly, while others process it more slowly or are more sensitive to its effects. This helps explain why the same treatment may work well for one person but less well for another, or why side effects can differ. These differences are common and are one part of how clinicians understand medication response.
What is Pharmacogenetics?
Pharmacogenetics examines how genetic variation can shape a person’s response to medications. By looking at the connection between genes and drugs, it helps explain why the same treatment may work differently from one person to another. For many medicines, genes can influence how strongly a drug works or how the body processes it. This information can support treatment decisions that are more informed and more individualized. You can read more about this topic in the LearnHub.
Drugs influenced by the RUNX2 gene
When should I seek medical advice?
There is not yet a broadly confirmed role for this gene in guiding how medicines are chosen or used. For concerns about side effects, how well a treatment is working, or changes in your health, it is best to speak with your doctor or pharmacist.
History
Features of cleidocranial dysplasia, the condition most closely linked to the RUNX2 gene, were described in medical reports long before the gene itself was found. In the late 20th century, researchers mapped the inherited condition to chromosome 6 and then identified changes in the RUNX2 gene, first called CBFA1, as the cause in many families. From these first observations, research expanded steadily. This discovery became an important milestone in skeletal genetics because it connected a recognizable pattern of delayed skull and collarbone development with a specific gene. As naming systems were updated, CBFA1 became known as the RUNX2 gene. That work helped shape modern understanding of inherited conditions affecting bone growth.